Elevated liver enzymes often present a diagnostic challenge to clinicians due to their diverse etiologies. A comprehensive, systematic approach is crucial for accurate diagnosis and management.
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are the most commonly evaluated liver enzymes. Elevation of these enzymes indicates hepatocyte injury but not the cause. Thus, understanding the pattern of liver enzyme elevation is key to narrow down the differential diagnoses.
Common causes include alcohol consumption, viral hepatitis, non-alcoholic fatty liver disease (NAFLD), and drug-induced liver injury. Less common causes include autoimmune hepatitis, hemochromatosis, and Wilson's disease. It's important to consider these possibilities, especially in the absence of common risk factors.
A comprehensive history and physical examination, combined with appropriate investigations, are the cornerstone of the diagnostic approach. Investigations should include hepatitis serology, autoantibodies, iron studies, and ceruloplasmin levels. In some cases, imaging studies or liver biopsy may be required.
Management should be tailored based on the underlying cause. For example, lifestyle modifications and weight loss are recommended for NAFLD, while antiviral therapy is the mainstay of treatment for viral hepatitis. In cases of drug-induced liver injury, discontinuation of the offending agent is crucial.
Diagnosing and managing elevated liver enzymes require a thorough understanding of the various etiologies and a systematic approach. By maintaining high clinical suspicion and utilizing appropriate investigations, clinicians can accurately diagnose and effectively manage patients with elevated liver enzymes, ultimately improving patient outcomes.
1.
For MDS-Related Anemia, Telomerase Inhibitor Approved.
2.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Treating Depression: Crucial for Recovery From Fibromyalgia
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights
2.
Immune Regulation of Blood Cell Development
3.
Exploring the Effects of Radiation Therapy on Cystitis: A Journey to Better Health
4.
Transformative Frameworks in Oncology for Better Care
5.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Understanding the causes of anemia in adults beyond nutritional deficiencies
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
5.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation